Professor | Weida Li | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Weida Li

Contact Information

liweida@tongji.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Tongji University
Faculty	Life Sciences
Academic Background & Achievements	Bachelor's Degree: Nankai University PhD: Peking University and Beijing Institute of Life Sciences Postdoctoral Research: Harvard Stem Cell Institute JDRF Fellowship Award Selected for the National High-level Young Talents Program in 2015
Work Experience	2015 - Present: Professor at Tongji University, School of Life Sciences and Technology 2015 - Present: Principal Investigator at the Ministry of Education's Center for Cell Potency and Fate Editing
Awards	JDRF Fellowship Award

University/Lab Affiliation and Title

Tongji University

Faculty

Life Sciences

Academic Background & Achievements

Work Experience

2015 - Present: Professor at Tongji University, School of Life Sciences and Technology
2015 - Present: Principal Investigator at the Ministry of Education's Center for Cell Potency and Fate Editing

Awards

Areas of Focus	Stem Cells and Regenerative Biology Transdifferentiation Diabetes Drug Development
Publications	ISR inhibition reverses pancreatic β-cell failure in Wolfram syndrome models, Hu R, Chen X, Su Q, Wang Z, Wang X, Gong M, Xu M, Le R, Gao Y, Dai P, Zhang ZN, Shao L, Li W, 2024 Charting a high-resolution roadmap for regeneration of pancreatic β cells by in vivo transdifferentiation from adult acinar cells, Liu G, Li Y, Li M, Li S, He Q, Liu S, Su Q, Chen X, Xu M, Zhang ZN, Shao Z, Li W, 2023 Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule, Yuan F, Li Y, Hu R, Gong M, Chai M, Ma X, Cha J, Guo P, Yang K, Li M, Xu M, Ma Q, Su Q, Zhang C, Sheng Z, Wu H, Wang Y, Yuan W, Bian S, Shao L, Zhang R, Li K, Shao Z, Zhang ZN, Li W, 2023

Areas of Focus

Stem Cells and Regenerative Biology
Transdifferentiation
Diabetes Drug Development

Publications

ISR inhibition reverses pancreatic β-cell failure in Wolfram syndrome models, Hu R, Chen X, Su Q, Wang Z, Wang X, Gong M, Xu M, Le R, Gao Y, Dai P, Zhang ZN, Shao L, Li W, 2024
Charting a high-resolution roadmap for regeneration of pancreatic β cells by in vivo transdifferentiation from adult acinar cells, Liu G, Li Y, Li M, Li S, He Q, Liu S, Su Q, Chen X, Xu M, Zhang ZN, Shao Z, Li W, 2023
Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule, Yuan F, Li Y, Hu R, Gong M, Chai M, Ma X, Cha J, Guo P, Yang K, Li M, Xu M, Ma Q, Su Q, Zhang C, Sheng Z, Wu H, Wang Y, Yuan W, Bian S, Shao L, Zhang R, Li K, Shao Z, Zhang ZN, Li W, 2023

Stem Cells Regeneration Biology Transdifferentiation Diabetes Drug Development Therapeutics Cell Therapy Biotechnology Molecular Biology

Li Weida - Tongji University

Lin Gufa - Tongji University

Zhang Zhenning - Tongji University

View All

Personal Information